References
- Stjernschantz J, Astin M. (1993). In: Edman P, ed. Biopharmaceutics of Ocular Drug Delivery. Boca Raton, FL: CRC Press, 1.
- Diane D-S, Tang L, Joseph BR, Robert JW, Harun T. (1994). Effects of four penetration enhancers on corneal permeability of drugs in vitro. J Pharm Sci, 83, 85–90.
- Fabrizio SM Patrizia C, Riccardo C, Gabriela M, Laura B. (1996). Evaluation of ocular permeation enhancers: in vitro effects on corneal transport of four β-blockers, and in vitro/in vivo toxic activity. Int J Pharm, 142, 103–13.
- Liu ZD, Li JW, Nie SF, Guo H, Pan WS. (2006). Effects of Transcutol P on the corneal permeability of drugs and evaluation of its ocular irritation of rabbit eyes. J Pharm Pharmacol, 58, 45–50.
- Sasaki H, Kojima M, Mori Y, Nakamura J, Shibasaki J. (1988). Enhancing effect of pyrrolidone derivatives on transdermal drug delivery I. Int J Pharm, 44, 15–24.
- Sasaki H, Kojima M, Nakamura J, Shibasaki J. (1990). Acute toxicity and skin irritation of pyrrolidone derivatives as transdermal penetration enhancer. Chem Pharm Bull, 38, 2308–10.
- Yoneto K, Ghanem AH, Higuchi WI, Peck KD, Li SK. (1995). Mechanistic studies of the 1-alkyl-2-pyrrolidones as skin permeation enhancers. J Pharm Sci, 84, 312–7.
- Koizumi A, Fujii M, Kondoh M, Watanabe Y. (2004). Effect of N-methyl-2-pyrrolidone on skin permeation of estradiol. Eur J Pharm Biol, 57, 473–8.
- Ren C, Fang L, Li T, Wang M, Zhao L, He Z. 2006. Effect of permeation enhancers and organic acids on the skin permeation of indapamide. Int J Pharm, 142, 103–13.
- Lee PJ, Ahmad N, Langer R, Mitragotri S, Shastri VP. (2006). Evaluation of chemical enhancers in the transdermal delivery of lidocaine. Int J Pharm, 308, 33–9.
- Draize JH, Woodard G, Calvery HO. (1944). Methods for the study of irritation and toxicity of substances. J Pharmacol Exp Ther, 82, 377–90.
- Fitzhugh OG, Woodard G, Braun HA. (1946). The toxicities of compounds related to 2,3-dimercaptopropanol(BAL) with a note on their relative therapeutic efficiency. J Pharm Exp Ther, 87 (suppl), 23–7.
- Schoenwald RD, Huang HS. (1983). Corneal penetration behavior of β-blocking agents I: Physico chemical factors. J Pharm Sci, 72, 1266–72.
- Camber O. (1985). An in vitro model for determination of drug permeability through the cornea. Acta Pharm Suec, 78, 815–9.
- Zhang L, Qi G, Zhu H. (2000). Study on pharmacokinetics of transdermal ionphoretic ibuprofen in rabbits. Chin Pharm J, 35, 189–91.
- Liu F. (2001). Determination of ribavirin in ribavirin eye drops. Chin Pharm, 12, 368–9.
- Liu ZD, Pan WS, Nie SF, Li JW, Liu HF. (2004). Investigation on the corneal permeability of enoxacin in vitro. Chin J New Drugs, 13, 1000–2.
- Song C, Yang X, Liu Z, Zhang Z, Pan W. (2007). Study on release profile of puerarin ophthalmic gel in vitro. Chin J New Drugs, 16, 2045–56.
- Hansen CM, Just L. 2001. Prediction of environmental stress cracking in plastics with Hansen solubility parameters. Ind Eng Chem Res, 40, 21–5.
- Akhter S, Barry BW. (1985). Absorption through human skin of ibuprofen and flurbiprofen; effect of dose variation, deposited drug film, occlusion and the penetration enhancer N-methyl-2-pyrrolidone. J Pharm Pharmacol, 37, 27–37.
- Yoneto K, Li SK, Ghanem AH, Crommelin DJ, Higuchi WI. (1995). A mechanistic study of the effects of the 1-alkyl-2-pyrrolidones on bilayer permeability of stratum corneum lipid liposomes: a comparison with hairless mouse skin studies. J Pharm Sci, 84, 853–60.
- Yoneto K, Li SK, Higuchi WI, Shimabayashi S. (1997). Influence of the permeation enhancers 1-alkyl-2-pyrrolidones on permeant partitioning into the stratum corneum. J Pharm Sci, 87, 209–14.
- Seki T, Kawaguchi T, Juni K, Sugibayashi K, Morimoto Y. (1991). Sustained transdermal delivery of zidovudine via controlled release of penetration enhancer. J Contr Rel, 17, 41–8.
- Maurice DM, Riley MV. (1970). Ocular pharmacokinetics. In: Gragmore CN, ed. Biochemistry of the Eye. London: Academic Press, 6–16.